Information on Research and Development
The strength of the Daiichi Sankyo Group is its powerful Research and Development capabilities, which have brought numerous new drugs to the global market . With the further strengthening of our research and development infrastructure through integration, synergic effect arising from the fusion of energetic researcher efforts and efficient R&D investment focused on our areas of expertise will be gained, enabling us to strive for the continuous development of drugs.
Huge Investments and a Lengthy Research Period
The development of a new drug is generally regarded to require roughly 9 to 17 years, and this period has an ongoing trend to further increase. Moreover, new drug development involves a long process, including both non-clinical and clinical trials (Phases I to III). Huge investments and a lengthy research period are required for this purpose.
Research and Development System
GEMRAD (“Global Executive Meeting of Research and Development”), the top decision-making organization that goes beyond the limits of conventional roles and regions in Research and Development at the Daiichi Sankyo Group, engages in important decision making activities including priority evaluation in the R&D pipeline and the proper distribution of R&D budget, and performs global management over research and development activities. This organization is comprised of a broad range of members representing the R&D division, domestic and overseas sales divisions, licensing division, and product portfolio division, forming a research and development system enabling the speedy development of new drugs.
Current Status of Research and Development
The following 5 projects were selected as prioritized projects:an anti-platelet agent, Prasugrel (CS-747); a factor Xa inhibitor(anticoagulants) DU-176b; an anti-hypertensive agent CS-8635, which is a triple combination of Olmesartan, Amlodipine and Hydrochlorothiazide; an anti-diabetes, Rivoglitazone(CS-011); an anti-RANKL antibody,Denosumab(AMG162). Daiichi-Sankyo Group is set to provide these 5 projects with the resources necessary to increase their speed of development.
